Jones Christy 4

What Happened
Christy Jones, a director of Beta Bionics, sold 2,811 common shares on 2026-06-04 at $14.00 per share, resulting in gross proceeds of $39,354. The sale is reported as an open-market/private sale (Code S) and was executed pursuant to a Rule 10b5-1 trading plan.

Key Details

• Transaction date and price: 2026-06-04 — 2,811 shares sold at $14.00 each.
• Total proceeds: $39,354 (gross).
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: Sale made under a 10b5-1 plan adopted February 19, 2026 (pre-established trading arrangement).
• Filing/timeliness: Form 4 filed 2026-06-05 for the 2026-06-04 transaction (appears timely).

Context
Sales under 10b5-1 plans are pre-scheduled and common for insiders; they do not necessarily reflect a change in view about the company. For retail investors, purchases tend to be a stronger signal than routine plan-driven sales.